Approvals/TGA/NIMENRIX Meningococcal (Groups A, C, W-135, Y) Polysaccharide Tetanus Toxoid Conjugate Vaccine, injection vial and diluent syringe

Approved

STANDARD

NIMENRIX Meningococcal (Groups A, C, W-135, Y) Polysaccharide Tetanus Toxoid Conjugate Vaccine, injection vial and diluent syringe

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 33c81fa2ba0e8abd
Product Name: NIMENRIX Meningococcal (Groups A, C, W-135, Y) Polysaccharide Tetanus Toxoid Conjugate Vaccine, injection vial and diluent syringe
Artg Id: 199742
Artg Name: NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2013-08-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c060db9ddc198d4a53b13eeb2dd3d823.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4f471b1ccb9476212a7379debe14f464.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

33c81fa2ba0e8abd

Type

Standard